Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bladder Cancer Carcinogens: Opportunities for Risk Reduction
Christopher Gaffney, Andrew Katims, Neeta D’Souza, et al.
European Urology Focus (2023) Vol. 9, Iss. 4, pp. 575-578
Open Access | Times Cited: 17

Showing 17 citing articles:

Mini-Review: Current Bladder Cancer Treatment—The Need for Improvement
Emily Gill, Claire M. Perks
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1557-1557
Open Access | Times Cited: 10
Risk Factors Associated with Urothelial Bladder Cancer
Souhail Alouini
International Journal of Environmental Research and Public Health (2024) Vol. 21, Iss. 7, pp. 954-954
Open Access | Times Cited: 8
Environmental Exposures and Canine Bladder Cancer: A Case Control Study Using Silicone Passive Samplers
Catherine F. Wise, Nicholas J. Herkert, Kate Hoffman, et al.
Environmental Science & Technology (2025)
Closed Access
Neoadjuvant Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Chemotherapy for Muscle-Invasive Urothelial Cancer: Large, Single-Center Analysis of Consecutive Patients’ Data
Łukasz Kwinta, Kamil Konopka, Krzysztof Okoń, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 258-258
Open Access
Dysregulation and antimetastatic function of circLRIG1 modulated by miR-214-3p/LRIG1 axis in bladder carcinoma
Shiliang Cheng, Chunguang Li, Lu Liu, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 3
Shame in patients undergoing ureterostomy: A cross‐sectional survey
Qin Li, Zhuo Lin, Ting Zhang
International Wound Journal (2024) Vol. 21, Iss. 3
Open Access | Times Cited: 1
Promoting effect and immunologic role of secretogranin II on bladder cancer progression via regulating MAPK and NF-κB pathways
Jiawei Zhou, Caitao Dong, Jing Tan, et al.
APOPTOSIS (2023) Vol. 29, Iss. 1-2, pp. 121-141
Closed Access | Times Cited: 3
The role of microbiota in tumorigenesis, progression and treatment of bladder cancer
Zijing Peng, Jingming Zhuang, Bing Shen
Microbiome Research Reports (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 3
Re: Christopher D. Gaffney, Andrew Katims, Neeta D’Souza, Marc A. Bjurlin, Richard S. Matulewicz. Bladder Cancer Carcinogens: Opportunities for Risk Reduction. Eur Urol Focus 2023;9:575–8
Yu‐Hsiang Lin, Han‐Yu Tsai, Horng‐Heng Juang
European Urology Focus (2024) Vol. 10, Iss. 2, pp. 242-243
Closed Access
From TURP to enucleation: navigating the complex relationship between BPH treatments and bladder cancer
Yu‐Hsiang Lin, Han‐Yu Tsai, Chun‐Te Wu
World Journal of Urology (2024) Vol. 42, Iss. 1
Closed Access
Re: Steven Monda, Manolis Pratsinis, Hansen Lui, et al. Secondary Bladder Cancer After Prostate Cancer Treatment: An Age-matched Comparison Between Radiation and Surgery. Eur Urol Focus. In press. http://doi.org/10.1016/j.euf.2023.09.002
Yu‐Hsiang Lin, Han‐Yu Tsai, Shu‐Han Tsao
European Urology Focus (2024) Vol. 10, Iss. 5, pp. 862-863
Open Access
Ebselen inhibits the proliferation and migration of bladder cancer by inducing autophagy and apoptosis
Shuaishuai Song, Qianhao Huang, Zhiyong Zhang, et al.
Research Square (Research Square) (2024)
Open Access
Urine microbiota and bladder cancer
Igor Yu. Lisitsyn, D. N. Maystrenko, Д. А. Гранов, et al.
Urology reports (St - Petersburg) (2024) Vol. 14, Iss. 3, pp. 315-330
Open Access
French AFU Cancer Committee Guidelines – Update 2024–2026: Non-muscle invasive bladder cancer (NMIBC)
M. Roumiguiè, Priscilla Léon, Évanguelos Xylinas, et al.
Deleted Journal (2024) Vol. 34, Iss. 12, pp. 102742-102742
Closed Access
Recommandations françaises du Comité de cancérologie de l’AFU – actualisation 2024–2026 : tumeurs de la vessie n’infiltrant pas le muscle (TVNIM)
M. Roumiguiè, Priscilla Léon, Évanguelos Xylinas, et al.
Progrès en Urologie - FMC (2024) Vol. 34, Iss. 7, pp. F272-F295
Closed Access
Doing Less with More: Towards a New Paradigm of Non–muscle-invasive Bladder Cancer Care
Max Kates
European Urology Focus (2023) Vol. 9, Iss. 4, pp. 555-556
Closed Access | Times Cited: 1
Carcinogens, environmental
Karen E. Iles, Dale A. Dickinson
Elsevier eBooks (2023), pp. 51-69
Closed Access
Page 1

Scroll to top